Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - OCULAR THERAPEUTIX, INC | ocul-20201231xex32d2.htm |
| EX-32.1 - EX-32.1 - OCULAR THERAPEUTIX, INC | ocul-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - OCULAR THERAPEUTIX, INC | ocul-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - OCULAR THERAPEUTIX, INC | ocul-20201231xex31d1.htm |
| EX-21.1 - EX-21.1 - OCULAR THERAPEUTIX, INC | ocul-20201231xex21d1.htm |
| EX-10.36 - EX-10.36 - OCULAR THERAPEUTIX, INC | ocul-20201231xex10d36.htm |
| EX-10.19 - EX-10.19 - OCULAR THERAPEUTIX, INC | ocul-20201231xex10d19.htm |
| EX-10.9 - EX-10.9 - OCULAR THERAPEUTIX, INC | ocul-20201231xex10d9.htm |
| 10-K - 10-K - OCULAR THERAPEUTIX, INC | ocul-20201231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-229085 333-230659 and 333-251327) and Form S-8 (Nos. 333-198240, 333-202886, 333-210059, 333-216622, 333-223513, 333-230126 and 333-237115) of Ocular Therapeutix, Inc. of our report dated March 11, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/PricewaterhouseCoopers LLP
Boston, Massachusetts
March 11, 2021